Covers gastrointestinal cancer targets—stage 1, 2, and 3 trials and preliminary results, as well as approved therapies.
Includes sections on Sequencing Technologies, and Targeted and Immunotherapy Agents.
Organizes information by tumor type, pathway, and drug name, so you can approach clinical challenges from any direction.
Highlights FDA approvals throughout.
Pocket-sized and color coded to help you find information quickly and easily.
Enrich Your eBook Reading Experience
Read directly on your preferred device(s), such as computer, tablet, or smartphone.
Easily convert to audiobook, powering your content with natural language text-to-speech.